Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)

NCT00780403 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergies

Interventions

DRUG: Desloratadine
DRUG: Zyrtec® (cetirizine)

Sponsor

Organon and Co